Medicus Pharma Ltd.MDCXEarnings & Financial Report
Nasdaq
MDCX Q3 2025 Key Financial Metrics
Revenue
$11.6K
Gross Profit
N/A
Operating Profit
$-15
Net Profit
$-20.9M
Gross Margin
N/A
Operating Margin
-0.1%
Net Margin
-180917.3%
YoY Growth
-79.2%
EPS
$-1.12
Financial Flow
Medicus Pharma Ltd. Q3 2025 Financial Summary
Medicus Pharma Ltd. reported revenue of $11.6K (down 79.2% YoY) for Q3 2025, with a net profit of $-20.9M (down 818.7% YoY) (-180917.3% margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $11.6K |
|---|---|
| Net Profit | $-20.9M |
| Gross Margin | N/A |
| Operating Margin | -0.1% |
| Report Period | Q3 2025 |
Medicus Pharma Ltd. Quarterly Revenue & Net Profit History
Medicus Pharma Ltd. results over the last 3 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 2025 | $11.6K | -79.2% | $-20.9M | -180917.3% |
| Q2 2025 | $40.0K | — | $-6.2M | -15438.7% |
| Q3 2024 | $55.5K | — | $-2.3M | -4104.8% |
Income Statement
| Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|
| Revenue | $55514 | $40004 | $11572 |
| YoY Growth | N/A | N/A | -79.2% |
Balance Sheet
| Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|
| Assets | N/A | $11.9M | $10.0M |
| Liabilities | N/A | $8.7M | $10.8M |
| Equity | $4.8M | $3.2M | $-910126 |
Cash Flow
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Operating CF | $-5.5M | $-6.8M |